Antiviral Activity of Bovine Interferons on Primate Cells
(Accepted x 9 March 1977) SUMMARY Potent preparations of bovine leucocyte and fibroblast interferons had substantial antiviral activity on monkey cells and low activity on human cells. Thus, interferon from a 'lower' phylogenetic species can have considerable antiviral activity in primate cells, but not all primate cells are equally sensitive.
The antiviral activity of interferons is often stated to be 'species-specific', although a number of exceptions have been reported. Human leukocyte interferon has pronounced antiviral activity in cells of the rabbit (Levy-Koenig, Golgher & Paucker, I97O; Stewart & Desmyter, I975) , cow, pig (Gresser et al. I974) and cat (Desmyter & Stewart, I976) , and slight activity in mouse, hamster (Borecky, Fuchsberger & Hajnicka, I974) and dog cells (Desmyter & Stewart, I976) . Human fibroblast interferon also exhibits a marked activity on rabbit cells (Desmyter, Rawls & Melnick, I968) , while human amnion and monkey cell interferons are active in rat cells (Duc-Goiran, Galliot & Chany, I97I ; Uhlendorf, Zimmerman & Baron, I973). In only one instance, however, has a fully characterized interferon from a lower species been shown to be active in primate cells: mouse interferon had I to 5% of its homologous activity in human amnion cells (Bodo, Palese & Lindner, I97I) . Culture fluids from calf kidney cells infected with viruses were reported to exert some antiviral activity in human and monkey cells (Sutton & Tyrrell, 196I ; Sellers & Fitzpatrick, I962 ), but the inhibitor described was of low activity and was not characterized as an interferon. We show here that potent preparations of bovine leukocyte and fibroblast interferons have substantial antiviral activity on monkey cells and low but consistent activity on human cells.
To prepare bovine interferon, bovine leukocytes obtained from Ficoll-Hypaque gradients of heparinized blood were incubated with agitation for 18 h at 37 °C at a concentration of lO 7 cells/ml in RPMI 164o medium with Io% foetal calf serum (GIBCO, U.S.A.), and with 2oo haemagglutination units (HAU) of Newcastle disease virus (NDV) per Io v cells. Bovine embryonic skin fibroblasts or bovine embryonic lung fibroblasts were induced with IOO HAU of NDV per lO 6 cells, or with Ioo/zg/ml of polyinosinic-polycytidylic acid complex (poly rI.poly rC; Boehringer, Germany) followed by treatment with cycloheximide (Io #g/ml) and actinomycin D (L #g/ml) according to the method described for other types of cells (Havell & Vil~ek, I972 ) . As necessary, interferon preparations were either dialysed against phosphate buffered saline (pH 7"4) to remove metabolic inhibitors or treated at pH 2 for at least 5 days to inactivate residual NDV (or in some instances ultracentrifuged, after which a rabbit anti-NDV serum was added to the supernatant).
Some details about the cells used for the assay of interferon are shown in Table I . All cells were cultivated in Eagle's minimal essential medium supplemented with lO% calf or foetal calf serum. Two methods were used to assay the interferons: (I) inhibition of the cytopathic effect (c.p.e.) of IOO TCDso of vesicular stomatitis virus (VSV) in cells grown as Short communications Our laboratory monolayer cultures in Microtest 2 (Falcon) plastic trays, as previously described (Gresser et al. I974) . Similarly, encephalomyocarditis (EMC) virus was used for challenge in some of the experiments presented. Titres are expressed as the reciprocal of the highest twofold dilution giving approx. 50% protection of the cell sheet; (2) inhibition of virus yield determined I8 h after the addition of VSV at a m.o.i, of I. Titres are expressed as reciprocals of the highest twofold dilution giving 90% virus yield reduction.
Bovine leukocyte interferon had significant antiviral activity on monkey BSC cells challenged with either VSV or EMC virus. The degree of crossing on BSC cells ranged between 3 and 75% of the homologous titre, with a median heterologous activity of 33% for four different preparations assayed 19 times. In contrast, the antiviral activity of bovine leukocyte interferon on human diploid fibroblasts was less marked, ranging from r to 25% of the homologous activity with a median of 3% based on ~5 titrations of 6 different preparations (representative titration results are shown in Table 2 ).
Bovine fibroblast interferon, induced with either NDV or poly rI.poly rC, also had a significant degree of antiviral activity on monkey BSC cells challenged with either VSV or EMC virus, with a heterologous activity that ranged between ~ and 2oo% of the titre on bovine cells (Table 2) . A median heterologous activity on BSC cells of zo% of the homologous titre was found with nine different preparations of bovine fibroblast interferon in a total of 35 determinations, only some of which are shown in Table 2 . As with the leukocyte interferon, the bovine fibroblast interferon had less activity on human fibroblast cells than on BSC cells (median titre 6% of the titre in bovine cells for 4 different preparations assayed on a total of 14 occasions).
The bovine leukocyte and fibroblast interferons fulfilled the usual criteria for the acceptance of a virus inhibitor as an interferon (Lockart, t973) when assayed on bovine, monkey and human cells, i.e. their activity was not affected by treatment with DNase, RNase, ultracentrifugation or dialysis, but was markedly reduced or completely destroyed by treatment with trypsin, sodium periodate, or heating at 6o °C for ~ h. The development of full activity required several hours incubation of the interferon with the cells and was not removed by washing the cells prior to addition of the challenge virus. In addition the antiviral activity of bovine fibroblast interferon was inhibited in both bovine and monkey cells by pre-treatment of the cells with actinomycin D. However, both bovine leukocyte and 
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--* Antiviral titre (reciprocal of dilution at endpoint) of interferon preparations determined by inhibition of c.p.e, on cells challenged with VSV unless otherwise indicated. All titres on the same line represent the values obtained in simultaneous assays on a given day.
t EMC virus used as a challenge.
fibroblast interferons were partially sensitive to acid pH, losing 50% of their activity on bovine, monkey and human cells after 24 h at pH 2.
The actual titre of a given bovine interferon preparation varied little from one occasion to another on the heterologous cells tested. In contrast, the titres on bovine cells were much more variable, and this may account for the apparent variations in the percentage of heterologous crossing which were observed on different occasions (e.g. between I and 200% of the homologous activity for bovine fibroblast interferon tested on monkey kidney cells, Table 2 ). We have no explanation for this variability in the titres on the homologous cells:
it was not correlated with the passage level of the bovine embryonic fibroblasts, and was not due to instability of the interferon preparation.
Human and monkey cells have similar sensitivities to both human and monkey interferons (Bucknall, I967 
